1. |
Hidalgo M, Cascinu S, Kleeff J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology, 2015, 15(1): 8-18.
|
2. |
Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2013. Ann Oncol, 2013, 24(3): 792-800.
|
3. |
Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet, 2004, 363(9414): 1049-1057.
|
4. |
Haller DG. New perspectives in the management of pancreas cancer. Semin Oncol, 2003, 30(4 Suppl 11): 3-10.
|
5. |
Wang Z, Li Y, Ahmad A, et al. Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol, 2011, 8(1): 27-33.
|
6. |
Clarke PG. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl), 1990, 181(3): 195-213.
|
7. |
Kondo Y, Kanzawa T, Sawaya R, et al. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer, 2005, 5(9): 726-734.
|
8. |
Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer, 2007, 7(12): 961-967.
|
9. |
White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer, 2012, 12(6): 401-410.
|
10. |
Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 2006, 10(1): 51-64.
|
11. |
Schwarze PE, Seglen PO. Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res, 1985, 157(1): 15-28.
|
12. |
Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncegene, 2004, 23(16): 2891-2906..
|
13. |
Liang XH, Kleeman LK, Jiang HH, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J ViroI, 1998, 72(11): 8586-8596.
|
14. |
Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ, 2011, 18(4): 571-580.
|
15. |
Rosenfeldt MT, O’Prey J, Morton JP, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature, 2013, 504(7479): 296-300.
|
16. |
Jonckheere N, Vincent A, Van Seuningen I. Of autophagy and in vivo pancreatic carcinogenesis: the p53 status matters! Clin Res Hepatol Gastroenterol, 2014, 38(4): 423-425.
|
17. |
Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomic, 1999, 59(1): 59-65.
|
18. |
Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999, 402(6762): 672-676.
|
19. |
Akar U, Ozpolat B, Mehta K, et al. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res, 2007, 5(3): 241-249.
|
20. |
Li X, Yan J, Wang L, et al. Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells. Cancer Cell Int, 2013, 13(1): 26.
|
21. |
Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest, 2003, 112(12): 1809-1820..
|
22. |
Rohatgi RA, Janusis J, Leonard D, et al. Beclin 1 regulates growth factor receptor signaling in breast cancer. Oncogene, 2015, 34(42): 5352-5362.
|
23. |
Katagiri H, Nakayama K, Razia S, et al. Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas. Int J Oncol, 2015, 47(6): 2037-2044.
|
24. |
康凯夫, 王晓蔚, 陈小伍, 等. Beclinl 在原发性肝细胞癌中的表达及其临床意义. 南方医科大学学报, 2009, 29(1): 151-153.
|
25. |
Li BX, Li CY, Peng RQ, et al. The expression of beclin 1 is associated with favorable prognosis in stage ⅢB colon cancers. Autophagy, 2009, 5(3): 303-306.
|
26. |
Wan XB, Fan XJ, Chen MY, et al. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy, 2010, 6(3): 395-404.
|
27. |
Giatromanolaki A, Koukourakis MI, Koutsopoulos A, et al. High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas. Gynecol Oncol, 2011, 123(1): 147-151.
|
28. |
Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature, 2008, 451(7182): 1069-1075.
|
29. |
Boya P, Gonzalez-Polo RA, Casares N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol, 2005, 25(3): 1025-1040.
|
30. |
Lum JJ, Bauer DE, Kong M, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell, 2005, 120(2): 237-248.
|
31. |
Gunn JM, Clark MG, Knowles SE, et al. Reduced rates of proteolysis in transformed cells. Nature, 1977, 266(5597): 58-60.
|
32. |
Kisen GO, Tessitore L, Costelli P, et al. Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis, 1993, 14(12): 2501-2505.
|
33. |
Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol, 2004, 2(4): 301-314.
|
34. |
Otsuka H, Moskowitz M. Differences in the rates of protein degradation in untransformed and transformed cell lines. Exp Cell Res, 1978, 112(1): 127-135.
|
35. |
Tóth S, Nagy K, Pálfia Z, et al. Cellular autophagic capacity changes during azaserine-induced tumour progression in the rat pancreas. Up-regulation in all premalignant stages and down-regulation with loss of cycloheximide sensitivity of segregation along with malignant transformation. Cell Tissue Res, 2002, 309(3): 409-416.
|
36. |
Chau YP, Lin SY, Chen JH, et al. Endostatin induces autophagic cell death in EAhy926 human endothelial cells. Histol Histopathol, 2003, 18(3): 715-726.
|